Chuan Li

1.8k total citations
97 papers, 1.3k citations indexed

About

Chuan Li is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Chuan Li has authored 97 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Hepatology, 49 papers in Epidemiology and 39 papers in Surgery. Recurrent topics in Chuan Li's work include Hepatocellular Carcinoma Treatment and Prognosis (62 papers), Liver Disease Diagnosis and Treatment (40 papers) and Liver Disease and Transplantation (20 papers). Chuan Li is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (62 papers), Liver Disease Diagnosis and Treatment (40 papers) and Liver Disease and Transplantation (20 papers). Chuan Li collaborates with scholars based in China, Japan and Hong Kong. Chuan Li's co-authors include Tianfu Wen, Wei Peng, Lünan Yan, Junyi Shen, Mingqing Xu, Tianfu Wen, Lvnan Yan, Bo Li, Jiayin Yang and Wentao Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Energy.

In The Last Decade

Chuan Li

93 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuan Li China 20 743 460 404 344 338 97 1.3k
Martha M. Kirstein Germany 19 496 0.7× 345 0.8× 423 1.0× 384 1.1× 157 0.5× 65 1.2k
Wei‐Chen Lee Taiwan 20 1.0k 1.4× 524 1.1× 551 1.4× 433 1.3× 290 0.9× 63 1.5k
Yonggang Wei China 22 885 1.2× 358 0.8× 796 2.0× 345 1.0× 171 0.5× 107 1.5k
Nobuyuki Takemura Japan 17 497 0.7× 322 0.7× 466 1.2× 355 1.0× 126 0.4× 93 1.1k
Jaume Boadas Spain 16 436 0.6× 421 0.9× 471 1.2× 570 1.7× 236 0.7× 36 1.2k
Maria B. Majella Doyle United States 17 855 1.2× 374 0.8× 786 1.9× 285 0.8× 136 0.4× 61 1.3k
Hironobu Amano Japan 20 663 0.9× 422 0.9× 667 1.7× 368 1.1× 109 0.3× 81 1.2k
Francis Chu Australia 19 512 0.7× 439 1.0× 468 1.2× 681 2.0× 105 0.3× 31 1.3k
Ismaïl Labgaa Switzerland 20 387 0.5× 170 0.4× 528 1.3× 443 1.3× 308 0.9× 74 1.2k

Countries citing papers authored by Chuan Li

Since Specialization
Citations

This map shows the geographic impact of Chuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan Li more than expected).

Fields of papers citing papers by Chuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan Li. The network helps show where Chuan Li may publish in the future.

Co-authorship network of co-authors of Chuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan Li. A scholar is included among the top collaborators of Chuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan Li. Chuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Hui‐Chuan, Zhiyong Huang, Lianxin Liu, et al.. (2025). Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study. Journal of Hepatocellular Carcinoma. Volume 12. 1043–1056.
2.
Zhang, Zhiwei, Jie Hui, Yi Liu, et al.. (2024). Analyzing dissemination, quality, and reliability of Chinese brain tumor-related short videos on TikTok and Bilibili: a cross-sectional study. Frontiers in Neurology. 15. 1404038–1404038. 10 indexed citations
3.
Meng, Chen, Sheng Yang, Shujun Zhang, et al.. (2024). Simulation of osteotomy in total knee arthroplasty with femoral extra-articular deformity assisted by artificial intelligence: a study based on three-dimensional models. Journal of Orthopaedic Surgery and Research. 19(1). 641–641.
4.
6.
Wang, Zhengxia, Junyi Shen, Chuwen Chen, Tianfu Wen, & Chuan Li. (2023). FOXA2 plays a critical role in hepatocellular carcinoma progression and lenvatinib-associated drug resistance. BioScience Trends. 17(2). 136–147. 9 indexed citations
7.
Wen, Tianfu, et al.. (2023). Nomogram to predict liver surgery-specific complications for hepatocellular carcinoma: A multicenter study. European Journal of Surgical Oncology. 49(12). 107119–107119. 2 indexed citations
9.
Peng, Wei, Xiaoyun Zhang, Chuan Li, et al.. (2022). Programmed cell death protein 1 and tyrosine kinase inhibition plus transcatheter arterial chemoembolization of advanced hepatocellular carcinoma. British journal of surgery. 110(7). 746–748. 6 indexed citations
10.
Tan, Min, Wuxiang Zhang, Yujuan Liu, et al.. (2022). VariScreen secures the screening of high-risk varices in patients with hepatitis B virus-related cirrhosis beyond Baveno VI criteria. Frontiers in Physiology. 13. 1006657–1006657. 1 indexed citations
11.
Wang, Xia, Yuping Zeng, He He, et al.. (2022). Biological variation of cardiovascular biochemical markers in patients with Type 2 Diabetes Mellitus. Clinica Chimica Acta. 534. 161–166. 1 indexed citations
12.
Shen, Junyi, Yu Zhang, Fengwei Gao, et al.. (2021). Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus‐related hepatocellular carcinoma after surgical resection: A multicenter study. Cancer Medicine. 10(23). 8421–8431. 15 indexed citations
13.
Zhang, Xiaoyun, Chuan Li, Tianfu Wen, et al.. (2020). The Different Effects of Nucleotide and Nucleoside Analogues on the Prognosis of HBV-Related HCC After Curative Resection. Journal of Gastrointestinal Surgery. 25(6). 1419–1429. 4 indexed citations
14.
Li, Chuan, Chang Liu, Tianfu Wen, et al.. (2019). The outcome of the HCC patients underwent ALPPS. Medicine. 98(38). e17182–e17182. 5 indexed citations
15.
Shen, Junyi, Li Tang, Xiaoyun Zhang, et al.. (2019). A Novel Index in Hepatocellular Carcinoma Patients After Curative Hepatectomy: Albumin to Gamma-Glutamyltransferase Ratio (AGR). Frontiers in Oncology. 9. 817–817. 19 indexed citations
16.
Shen, Junyi, Chuan Li, Lvnan Yan, et al.. (2017). Short- and Long-term Outcomes between Young and Older HCC Patients Exceeding The Milan Criteria after Hepatectomy. Annals of Hepatology. 17(1). 134–143. 11 indexed citations
17.
18.
Shen, Junyi, Chuan Li, Tianfu Wen, et al.. (2016). Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy. Journal of Surgical Research. 209. 102–111. 25 indexed citations
19.
Li, Chuan, Tianfu Wen, Lvnan Yan, et al.. (2016). Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria. Journal of Surgical Research. 209. 8–16. 17 indexed citations
20.
Li, Chuan, Jingyi Zhang, Xiaoyun Zhang, Tianfu Wen, & Lünan Yan. (2015). FibroScan predicts ascites after liver resection for hepatitis B virus-related hepatocellular carcinoma: A prospective cohort study. International Journal of Surgery. 20. 21–25. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026